Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free
Close

Editas Medicine Inc (EDIT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Editas Medicine's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
12.16 -1.24    -9.25%
15:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
12.28
+0.12
+0.99%
19:34:53 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,783,732
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 12.05 - 13.05
Editas Medicine 12.16 -1.24 -9.25%

Editas Medicine Inc Company Profile

 
Get an in-depth profile of Editas Medicine Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology
SectorHealthcare
Employees

264

Equity Type

ORD

Editas Medicine, Inc. is a clinical-stage gene editing company. The Company is focused on developing transformative gene editing medicines to treat a range of serious diseases. It has developed a gene editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 (Cas9) or CRISPR from Prevotella and Francisella 1 (Cpf1), bound to a guide RNA molecule designed to recognize a particular deoxyribonucleic acid (DNA) sequence. The Company is focused on both in vivo gene editing medicines, in which the medicine is injected or infused into the patient to edit the cells inside their body, and ex vivo gene-edited cell medicines, in which cells are edited with its technology. The Company's gene editing medicine programs include EDIT-101, EDIT-102, EDIT-103, EDIT-301 and EDIT-202.

Contact Information

Top Executives

Name Age Since Title
Akshay K. Vaishnaw 59 2016 Independent Director
Andrew J. Hirsch 51 2017 Independent Director
David T. Scadden 68 2019 Independent Director
Meeta Chatterjee 66 2020 Independent Director
Emma Reeve 61 2021 Independent Director
Bernadette Mary Connaughton 64 2021 Independent Director
Jessica Hopfield 57 2018 Independent Lead Director
James C. Mullen 63 2018 Executive Chairman
George McDonald Church 68 2013 Co-Founder & Scientific Advisory Board Member
J. Keith Joung - 2013 Co-Founder & Scientific Advisory Board Member
Feng Zhang - 2013 Co-Founder & Scientific Advisory Board Member
David R. Liu - 2013 Co-Founder & Scientific Advisory Board Member
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

EDIT Comments

Write your thoughts about Editas Medicine Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Khalifa Almannaei
Khalifa Almannaei May 18, 2022 5:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bullish
Gregg Alvarez
Gregg Alvarez Mar 22, 2022 5:18PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I waited for over a year to come to what I think is a steal. I thought it was never going to happen, honestly. Haha. Got some nice swing trades though. Hoarded a lot below 15. I hope this is a bottom. If not, oh well. Personally, I think this is a
andrew mccorkle
andrew mccorkle Mar 22, 2022 5:18PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
mk9>98
steve barone
steve barone Oct 08, 2021 6:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this company's stock price needs to start moving in the upward direction!
Bryan has blocked CIA
Bryan has blocked CIA Oct 07, 2021 1:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
the Company will present preclinical data on its progress in the development of cell therapy medicines for the treatment of cancer at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting being held in Washington, D.C., and virtually, November 10-14, 2021.The Company will present a poster on its new method to drive high-level constitutive CD16 expression on the surface of iPSC-derived natural ***(iNK) cells through transgene knock-in (KI) at the GAPDH locus using an Editas-engineered AsCas12a. New preclinical data demonstrated that CD16 KI confers significantly increased cytotoxic activity in iNK cells against tumor cells compared with wild type iNK cells.
Bryan has blocked CIA
Bryan has blocked CIA Oct 07, 2021 10:23AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this 37 dollar price point seems to me a very strong support.
TRDA AAL
TRDA AAL Sep 29, 2021 2:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is it worthy to invest in this stock?
Willy Tsai
Willy Tsai Sep 29, 2021 2:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Christian Rasmussen
Christian Rasmussen Sep 29, 2021 9:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I don't get it. Fantastic results, and the shareprice drops like a rock!?
Bryan has blocked CIA
Bryan has blocked CIA Sep 29, 2021 9:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
well, now it is looking like a buy at 38 dollar. There is a very strong trendline there
Bryan has blocked CIA
Bryan has blocked CIA Sep 29, 2021 8:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Today is the day.
Yasser Abdulhadi
Yasser Abdulhadi Sep 29, 2021 8:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
For what exacty !!!
Bryan has blocked CIA
Bryan has blocked CIA Sep 29, 2021 8:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
for positive research results on low and mid dose + a sell off xD
Mustafa Mond
Mustafa Mond Sep 14, 2021 12:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ark invest sold 90,000 share of editas
Bryan has blocked CIA
Bryan has blocked CIA Sep 10, 2021 10:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Company to host webcast investor event following the presentation on September 29 at 11:00 a.m. ET. Editas Medicine, a leading genome editing company, announced that an abstract featuring initial clinical data from the BRILLIANCE clinical trial of EDIT-101 has been selected for an oral presentation at the XIXth International Symposium on Retinal Degeneration
Bryan has blocked CIA
Bryan has blocked CIA Sep 10, 2021 10:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Results on september 29th , not september 10 th
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email